These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7201009)

  • 1. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S
    Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery.
    Tani E; Maeda Y; Fukumori T; Nakano M; Kochi N; Morimura T; Yokota M; Matsumoto T
    J Neurosurg; 1984 Jul; 61(1):24-9. PubMed ID: 6539367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y; Handa H; Okamoto S; Ohta T; Kamijo Y; Oda Y; Kondo A; Nin K; Yamamoto T; Ban S
    Nihon Geka Hokan; 1986 May; 55(3):473-84. PubMed ID: 3541826
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
    Chan RC; Durity FA; Thompson GB; Nugent RA; Kendall M
    J Neurosurg; 1984 Dec; 61(6):1120-8. PubMed ID: 6389786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N
    Acta Med Okayama; 1984 Jun; 38(3):239-50. PubMed ID: 6380217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study.
    Suzuki S; Iwabuchi T; Tanaka T; Kanayama S; Ottomo M; Hatanaka M; Aihara H
    Acta Neurochir (Wien); 1985; 77(3-4):133-41. PubMed ID: 2933930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.
    Kaminogo M; Yonekura M; Onizuka M; Yasunaga A; Shibata S
    Neurol Med Chir (Tokyo); 1998 Nov; 38(11):704-8; discussion 708-9. PubMed ID: 9919901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins.
    Yokota M; Tani E; Fukumori T; Maeda Y; Yamaura I
    Surg Neurol; 1991 May; 35(5):345-9. PubMed ID: 2028380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
    Komatsu H; Takehana Y; Hamano S; Ujiie A; Hiraku S
    Jpn J Pharmacol; 1986 Jul; 41(3):381-91. PubMed ID: 3761754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.
    Tokiyoshi K; Ohnishi T; Nii Y
    Surg Neurol; 1991 Aug; 36(2):112-8. PubMed ID: 1891755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
    Chung KF; Aizawa H; Becker AB; Frick O; Gold WM; Nadel JA
    Am Rev Respir Dis; 1986 Aug; 134(2):258-61. PubMed ID: 3509981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.
    Suzuki S; Sano K; Handa H; Asano T; Tamura A; Yonekawa Y; Ono H; Tachibana N; Hanaoka K
    Neurol Res; 1989 Jun; 11(2):79-88. PubMed ID: 2569686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the cutaneous response to antigen by a thromboxane-synthetase inhibitor (OKY-046) in allergic dogs.
    Becker AB; Chung KF; Aizawa H; Frick OL; Gold WM
    J Allergy Clin Immunol; 1989 Aug; 84(2):206-13. PubMed ID: 2760361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.
    Kwan AL; Lin CL; Yen CP; Winardi W; Su YF; Winardi D; Dai ZK; Jeng AY; Kassell NF; Howng SL; Wang CJ
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries.
    Chan PD; Findlay JM; Vollrath B; Cook DA; Grace M; Chen MH; Ashforth RA
    J Neurosurg; 1995 Sep; 83(3):522-30. PubMed ID: 7666232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046).
    Tomoda H
    Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of timing of clot removal on chronic vasospasm in a primate model.
    Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
    J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.